Kiora Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Kiora Pharmaceuticals

10/08/2023 12:47

* Kiora Pharmaceuticals Inc  KPRX.OQ  reported a quarterly
adjusted loss of 79 cents​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of $1.07 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Kiora Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 79 cents​.
    * The mean earnings estimate of analysts had risen by
about 15.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Kiora Pharmaceuticals Inc shares had fallen by 13.5% this
quarter and lost 83.8% so far this year.
    * The company reported a quarterly loss of $2.61 million.
    * Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 11:47 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.07          -0.79          Beat
 Mar. 31 2023      -1.68          -1.00          Beat
 Dec. 31 2022      -2.46          -1.76          Beat
 Sep. 30 2022      -3.83          -6.03          Missed